Duloxetine Capsule, Delayed Release
Product Images NDC 50090-6900
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-6900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure10 (Duloxetine Fig10)
Figure2 (Duloxetine Fig2)
This text appears to be a graph showing the proportion of patients with relapse over time for two treatments: placebo and duloxetine. The graph displays a time scale on the x-axis (measured in days) and the proportion of patients with relapse on the y-axis. The data points are labeled with numerical values, indicating the proportion of patients at each time point. The treatments are represented by two lines on the graph, one for placebo and one for duloxetine. The graph suggests that duloxetine may be more effective at preventing relapse compared to the placebo.*
Figure3 (Duloxetine Fig3)
Figure4 (Duloxetine Fig4)
Figure5 (Duloxetine Fig5)
Figure6 (Duloxetine Fig6)
Figure7 (Duloxetine Fig7)
Figure8 (Duloxetine Fig8)
Figure9 (Duloxetine Fig9)
Structure (Duloxetine Structure)
Label Image (Lbl500906900)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.